IndegeneNSE:INDGN +2.69%49 Market Cap is ₹122,691 Mil as of Jul. 12, 2026. GuruFocus rates NSE:INDGN with a GF Score™ of 49/100. The stock has 5 warning signs investors should review. Among 697 Healthcare Providers & Services companies, Indegene ranks better than 83.5% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Indegene's share price for the quarter that ended in Mar. 2026 was ₹434.6. Indegene's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 241 Mil. Therefore, Indegene's market cap for the quarter that ended in Mar. 2026 was ₹104,696 Mil.
Indegene's quarterly market cap
declined
from Sep. 2025 (₹134,719 Mil) to Dec. 2025 (₹125,073 Mil) and
declined
from Dec. 2025 (₹125,073 Mil) to Mar. 2026 (₹104,696 Mil).
Indegene's annual market cap
increased
from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹138,845 Mil) but then
declined
from Mar. 2025 (₹138,845 Mil) to Mar. 2026 (₹104,696 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Indegene's Enterprise Value for Today is ₹109,218 Mil.
Indegene (NSE:INDGN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Indegene Market Cap Related Terms
Indegene Market Cap Historical Data
* Premium members only.
The historical data trend for Indegene's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDGN vs VEEV, BTSG, TEM: Market Cap Comparison
For the Health Information Services subindustry, Indegene's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indegene Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indegene's Market Cap distribution charts can be found below:
* The bar in red indicates where Indegene's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Indegene's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indegene (NSE:INDGN) has a Market Cap of ₹122,691 Mil as of Jul. 12, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Indegene and its competitors. According to the industry distribution chart, Indegene ranks #115 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 16.5%.
Is Indegene's Market Cap too high?
Indegene's current Market Cap is ₹122,691 Mil. Based on the distribution chart, Indegene ranks #115 out of 697 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Indegene has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Indegene's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Indegene ranks #115 out of 697 companies for Market Cap. This places Indegene in the top 17% of its industry — outperforming the majority of peers. The industry median Market Cap is 102.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 102.47, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Indegene and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 102.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indegene's current Market Cap is ₹122,691 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indegene stock overvalued right now?
Indegene (NSE:INDGN) has a current Market Cap of ₹122,691 Mil. The current Market Cap is ₹122,691 Mil. Indegene's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Indegene (NSE:INDGN), the current Market Cap is ₹122,691 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.
49GF Score
Get the complete analysis for NSE:INDGN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDGN has been successfully added to your 
